|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/0014 | (2013.01) | ||
| A61K 9/06 | (2006.01) | ||
| A61K 9/06 | (2013.01) | ||
| A61P 17/04 | (2006.01) | ||
| A61K 35/74 | (2013.01) | ||
| A61K 35/74 | (2015.01) | ||
| A61P 17/04 | (2018.01) |
| (11) | Number of the document | 3445330 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17723547.0 |
| Date of filing the European patent application | 2017-04-18 | |
| (97) | Date of publication of the European application | 2019-02-27 |
| (45) | Date of publication and mention of the grant of the patent | 2022-07-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/028133 |
| Date | 2017-04-18 |
| (87) | Number | WO 2017/184601 |
| Date | 2017-10-26 |
| (30) | Number | Date | Country code |
| 201662324762 P | 2016-04-19 | US |
| (72) |
MYLES, Ian, Antheni , US
DATTA, Sandip, K. , US
|
| (73) |
The U.S.A. as represented by the Secretary,
Department of Health and Human Services ,
National Institutes of Health
Office of Technology Transfer
6701 Rockledge Drive, Suite 700
MS 7788, Bethesda, MD 20892,
US
|
| (54) | USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS |
| USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS |